Cyril Amarchand Mangaldas advised the book running lead managers on Anthem Biosciences Limited’s IPO
Cyril Amarchand Mangaldas advised the book running lead managers — JM Financial Limited, Citigroup Global Markets India Private Limited, J.P. Morgan India Private Limited, and Nomura Financial Advisory and Securities (India) Private Limited — in connection with the initial public offering (IPO) of Anthem Biosciences Limited.
Anthem is an innovation-driven and technology-focused contract research, development and manufacturing organization (CRDMO) with fully integrated operations spanning drug discovery, development, and manufacturing. The IPO was a pure offer for sale of equity shares by certain existing shareholders, aggregating to ₹33,950 million. The equity shares were listed on the stock exchanges on July 21, 2025, with the issue oversubscribed 63.86 times, delivering a premium of 26.85% over the issue price of ₹570.
The Cyril Amarchand Mangaldas deal team was led by Reuben Chacko (Partner & Regional Co-Head – Capital Markets – South) and Vartika Jain (Partner), with assistance from Bhaskar Kumar (Associate), Dhruv Sharma (Associate), Prakhar Jain (Associate), Joe George (Associate), and Rakshitha V (Associate).
Click to know more about Cyril Amarchand Mangaldas
If you have a news or deal publication or would like to collaborate on content, columns, or article publications, connect with the Legal Era News Network Team and email us at [email protected] or call us on +91 88796 34922.